Population based time trends and socioeconomic variation in use of radiotherapy and radical surgery for prostate cancer in a UK region: Continuous survey

BMJ (Online)

Volumn 340, Issue 7753, 2010, Pages 961-

  Lyratzopoulos, Georgios ^a   Barbiere, Josephine M ^a   Greenberg, David C ^b   Wright, Karen A ^b   Neal, David E ^c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b Eastern Cancer Registration and Information Centre   (United Kingdom)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; CANCER SURGERY; COMPARATIVE STUDY; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROSTATE CANCER; SOCIAL STATUS; UNITED KINGDOM;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; DELIVERY OF HEALTH CARE; ENGLAND; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RESIDENCE CHARACTERISTICS; SOCIOECONOMIC FACTORS;

EID: 77951700024     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.c1928     Document Type: Article

References (48)

1. Quinn M, Babb P. Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: international comparisons. BJU Int 2002;90:162-173
2. National Cancer Intelligence Network. Cancer incidence by deprivation England, 1995-2004. http://library.ncin.org.uk/docs/081202-NCIN-Incidence-by- Deprivation-95-04.pdf.
3. Quinn MJ, Babb P, Brock A, Kirby L, Jones J. Cancer trends in England and Wales 1950-1999. Studies on medical and population subjects No 66. Office for National Statistics, 2001.
4. Rachet B, Maringe C, Nur U, Quaresma M, Shah A, Woods LM, et al. Population-based cancer survival trends in England and Wales up to 2007: an assessment of the NHS cancer plan for England. Lancet Oncol 2009;10:351-369
5. Rowan S, Rachet B, Alexe DM, Cooper N, Coleman MP. Survival from prostate cancer in England and Wales up to 2001. Br J Cancer 2008;99(suppl 1):75-7S.
6. Jeffreys M, Sarfati D, Stevanovic V, Tobias M, Lewis C, Pearce N, et al. Socioeconomic inequalities in cancer survival in New Zealand: the role of extent of disease at diagnosis. Cancer Epidemiol Biomarkers Prev 2009;18:915-921
7. Marsa K, Johnsen NF, Bidstrup PE, Johannesen-Henry CT, Friis S. Social inequality and incidence of and survival from male genital cancer in a population-based study in Denmark, 1994-2003. Eur J Cancer 2008;44:2018-2029
8. Clarke NW. Survival from prostate cancer in England and Wales up to 2001. Br J Cancer 2008;99(suppl 1):78-9S.
9. Melia J, Moss S, Johns L, contributors in the participating laboratories. Rates of prostate-specific antigen testing in general practice in England and Wales in asymptomatic and symptomatic patients: a cross-sectional study. BJU Int 2004;94:51-56
10. Hoffman RM, Stone SN, Espey D, Potosky AL. Differences between men with screening-detected versus clinically diagnosed prostate cancers in the USA. BMC Cancer 2005;5:27. (Pubitemid 41461101)
11. National Institute for Health and Clinical Excellence. Prostate cancer diagnosis and treatment. Quick reference guide. 2008. www.nice. org.uk/nicemedia/pdf/CG58QuickRefGuide.pdf.
12. ProtecT Study (prostate testing for cancer and treatment). University of Bristol, 2009. www.epi.bris.ac.uk/protect/.
13. Penson DF. Variations in prostate cancer patterns of care: is it the quality of care or the quality of the data? J Clin Oncol 2005;23:7783-7784
14. Sobin LH, Wittekind Ch, eds. International Union Against Cancer (UICC). TNM classification of malignant tumors. 5th ed. John Wiley, 1997.
15. Indices of deprivation 2004. Communities and local government. www.communities.gov.uk/archived/general-content/communities/ indicesofdeprivation/216309/.
16. Woods LM, Rachet B, Coleman MP. Choice of geographic unit influences socioeconomic inequalities in breast cancer survival. Br J Cancer 2005;92:1279-1282 (Pubitemid 40604404)
17. NHS Connecting for Health. OPCS-4 intervention classification. 2010. www.connectingforhealth.nhs.uk/systemsandservices/data/clinicalcoding/ codingstandards/opcs4.
18. Oliver SE, Donovan JL, Peters TJ, Frankel S, Hamdy FC, Neal DE. Recent trends in the use of radical prostatectomy in England: the epidemiology of diffusion. BJU Int 2003;91:331-336 (Pubitemid 36359636)
19. Krupski TL, Kwan L, Afifi AA, Litwin MS. Geographic and socioeconomic variation in the treatment of prostate cancer. J Clin Oncol 2005;23:7881-7888 (Pubitemid 46657386)
20. Fairley L, Baker M, Whiteway J, Cross W, Forman D. Trends in nonmetastatic prostate cancer management in the Northern and Yorkshire region of England, 2000-2006. Br J Cancer 2009;10:1839-1845
21. Hayen A, Smith DP, Patel MI, O'Connell DL. Patterns of surgical care for prostate cancer in NSW, 1993-2002: rural/urban and socioeconomic variation. Aust N Z J Public Health 2008;32:417-420
22. Hall SE, Holman CD, Wisniewski ZS, Semmens J. Prostate cancer: socio-economic, geographical and private-health insurance effects on care and survival. BJU Int 2005;95:51-58 (Pubitemid 350020869)
23. Smith JA Jr, Chan RC, Chang SS, Herrell SD, Clark PE, Baumgartner R, et al. A comparison of the incidence and location of positive surgical margins in robotic assisted laparoscopic radical prostatectomy and open retropubic radical prostatectomy. J Urol 2007;178:2385-2389
24. Richstone L, Bianco FJ, Shah HH, Kattan MW, Eastham JA, Scardino PT, et al. Radical prostatectomy in men aged >or=70 years: effect of age on upgrading, upstaging, and the accuracy of a preoperative nomogram. BJU Int 2008;101:541-546 (Pubitemid 351199287)
25. Bott SR, Freeman AA, Stenning S, Cohen J, Parkinson MC. Radical prostatectomy: pathology findings in 1001 cases compared with other major series and over time. BJU Int 2005;95:34-39 (Pubitemid 350020866)
26. Harlan LC, Potosky A, Gilliland FD, Hoffman R, Albertsen PC, Hamilton AS, et al. Factors associated with initial therapy for clinically localized prostate cancer: prostate cancer outcomes study. J Natl Cancer Inst 2001;93:1864-1871 (Pubitemid 34048653)
27. Rapiti E, Fioretta G, Schaffar R, Neyroud-Caspar I, Verkooijen HM, Schmidlin F, et al. Impact of socioeconomic status on prostate cancer diagnosis, treatment, and prognosis. Cancer 2009;115:5556-5565
28. Smith DP, King MT, Egger S, Berry MP, Stricker PD, Cozzi P, et al. Quality of life three years after diagnosis of localised prostate cancer: population based cohort study. BMJ 2009;339:b4817.
29. Lyratzopoulos G, Heller RF, Hanily M, Lewis PS. Risk factor measurement quality in primary care routine data was variable but nondifferential between individuals. J Clin Epidemiol 2008;61:261-267 (Pubitemid 351146632)
30. British Association of Urological Surgeons, Section of Oncology. BAUS Cancer Registry. Analyses of minimum data set for urological cancers. January 1st-31st December 2006. October 2007. www.sarahfowler.org/2006finalanalyses.pdf.
31. Albain KS, Unger JM, Crowley JJ, Coltman CA Jr, Hershman DL. Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group. J Natl Cancer Inst 2009;101:984-992
32. Office for National Statistics. Past estimates-population estimates by ethnic group mid-2001-2006 (experimental). 2010. www.statistics.gov.uk/statbase/ Product.asp?vlnk=14238.
33. National Cancer Intelligence Network. England: cancer incidence and survival by major ethnic group, 2002-2006. http://library.ncin.org.uk/docs/ 090625-NCIN-Incidence-and-Survival-by-Ethnic-Group-Report.pdf .
34. Wilt TJ, Shamliyan TA, Taylor BC, MacDonald R, Kane RL. Association between hospital and surgeon radical prostatectomy volume and patient outcomes: a systematic review. J Urol 2008;180:820-828
35. Liberatos P, Link BG, Kelsey JL. The measurement of social class in epidemiology. Epidemiol Rev 1988;10:87-121.
36. Carstairs V, Morris R. Deprivation and mortality: an alternative to social class? Community Med 1989;11:210-219
37. Krieger N,Williams DR,Moss NE.Measuring social class in US public health research: concepts, methodologies, and guidelines. Annu Rev Public Health 1997;18:341-378
38. Smith GD, Hart C, Watt G, Hole D, Hawthorne V. Individual social class, area-based deprivation, cardiovascular disease risk factors, andmortality: the Renfrewand Paisley Study. J Epidemiol Community Health 1998;52:399-405. (Pubitemid 28438526)
39. Bentley R, Kavanagh AM, Subramanian SV, Turrell G. Area disadvantage, individual socio-economic position, and premature cancer mortality in Australia 1998 to 2000: a multilevel analysis. Cancer Causes Control 2008;19:183-193
40. Shohaimi S, Welch A, Bingham S, Luben R, Day N, Wareham N, Khaw KT. Area deprivation predicts lung function independently of education and social class. Eur Respir J 2004;24:157-161 (Pubitemid 39029082)
41. Sloggett A, Young H, Grundy E. The association of cancer survival with four socioeconomic indicators: a longitudinal study of the older population of England and Wales 1981-2000. BMC Cancer 2007;7:20.
42. Bill-Axelson A, Holmberg L, Filén F, Ruutu M, Garmo H, Busch C, et al. Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial. J Natl Cancer Inst 2008;100:1144-1154
43. Bolla M, Collette L, Blank L, Warde P, Dubois JB, Mirimanoff RO, et al. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial. Lancet 2002;360:103-106
44. Davison BJ, Parker PA, Goldenberg SL. Patients' preferences for communicating a prostate cancer diagnosis and participating in medical decision-making. BJU Int 2004;93:47-51.
45. Kim SP, Knight SJ, Tomori C, Colella KM, Schoor RA, Shih L, et al. Health literacy and shared decision making for prostate cancer patients with low socioeconomic status. Cancer Invest 2001;19:684-691
46. Swords K, Wallen EM, Pruthi RS. The impact of race on prostate cancer detection and choice of treatment in men undergoing a contemporary extended biopsy approach. Urol Oncol 2008 Dec 11 [Epub ahead of print].
47. Shavers VL, Brown ML, Potosky AL, Klabunde CN, Davis WW, Moul JW, et al. Race/ethnicity and the receipt of watchful waiting for the initial management of prostate cancer. J Gen Intern Med 2004;19:146-155 (Pubitemid 38368463)
48. Shavers VL, Brown M, Klabunde CN, Potosky AL, Davis W, Moul J, et al. Race/ethnicity and the intensity of medical monitoring under "watchful waiting" for prostate cancer. Med Care 2004;42:239-250